Novavax and BioNTech closed down more than 7%, with almost all of the losses coming after news broke of the selection—Novavax ...

Trump announced his decision in a tweet following media reports that Kennedy would be his choice to lead the federal health ...

Gaetz, whose nomination requires Senate approval, resigned from his seat in the US House of Representatives in light of the ...

As the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory ...

BANGKOK—The Chinese Consulate in Myanmar’s second-largest city has been slightly damaged by an explosive device, but there were no casualties, the military, independent media and a city resident said ...

BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced ...

Some analysts have estimated the market could be worth as much as $150 billion by the early 2030s. U.S-based Catalent, one of ...

Biotech firm Novavax dropped 9.1% after cutting its annual revenue forecast due to lower-than-expected sales of its COVID-19 ...

In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Novavax (NVAX – Research Report), with a price target ...

Investors are assessing whether the post-election rally is about to stall and what Donald Trump's Cabinet picks mean for ...

A traffic collision involving a big-rig and a car on Highway 99, just south of Briggsmore Avenue, forced multiple lanes to be ...

Novavax Inc. closed $15.40 short of its 52-week high ($23.86), which the company achieved on June 6th. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated ...